- SG$77.02m
- SG$77.55m
- $0.35m
Chair
Brief: Trendlines Group Says Sees Higher Net Loss For FY23
Brief: Trendlines Sees Net Loss For Year Ended 31 December 2023 Of Between $25-$30 Million
Brief: Trendlines Group Says Haim Brosh, Currently Company's CFO To Be Named CEO And Interim CFO
Brief: Trendlines Group Says Cessation Of Steve Rhodes As CEO
Brief: Trendlines Group Says Cessation Of Todd Dollinger As Chief Executive Officer
Brief: Trendlines Group Updates On Israel Situation
Brief: Trendlines Group Posts HY Net Profit Attributable Of $4.5 Million
Brief: Trendlines Group Expects To Report A Net Profit For Six Months
Brief: Omeq Medical Receives FDA Regulatory Clearance For Its Device For Epidural Injections
Brief: Trendlines Group Posts 2022 Net Loss $15.0 Million
Brief: Trendlines Group Announces Strategic Transformation Plan & Business Update Presentation
Brief: Trendlines Invests In Celleste Bio
Brief: Trendlines Group Says Approved Investments In Three Trendlines Portfolio Companies By Agriline Ltd And Group
Brief: Trendlines Group Ltd Sees HY Net Loss Of Us$11.9 Mln Vs Us$4.1 Mln
Brief: Trendlines Expects To Report A Net Loss For Six Months Ended 30 June 2022
Brief: Escala Medical Receives FDA Regulatory Clearance
Brief: Trendlines Group FY Net Income After Tax Us$6.0 Million
Brief: SetBone Medical Announces $1.6 Million Financing